SPHK1 and cancer: However, contrary to chemoresistance that was shown in PC3 and DU145 cells16, SK1 overexpression did not abrogate RAD001-induced reduction in VEGF in prostate (PC3) and breast (MDA-MB-231) cancer models, suggesting that the two pathways are regulated independently.